I E Pyott David
Director · 6 filings · Latest: Sep 15, 2026
ALNYLAM PHARMACEUTICALS, INC.
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | I E Pyott David | Director | Sep 15, 2026 | Option Exercise | — | 201 | — | 9,575 | |
ALNY | I E Pyott David | Director | Jun 1, 2026 | Sale | $299.18 | 3,830 | $1.1M | 1,582 | |
ALNY | I E Pyott David | Director | Jun 1, 2026 | Option Exercise | $0.00 | 3,830 | — | 5,412 | |
ALNY | PYOTT DAVID E I | — | Jun 1, 2026 | Proposed Sale | $299.51 | 3,830 | $1.1M | — | |
TARS | I E Pyott David | Director | Apr 24, 2026 | Option Exercise | — | 1,383 | — | 1,383 | |
ALNY | PYOTT DAVID E I | — | Mar 24, 2025 | Proposed Sale | $299.00 | 7,440 | $2.2M | — |